skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Refinado por: tipo de recurso: Artigos remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
SN-38, the active metabolite of irinotecan, inhibits the acute inflammatory response by targeting toll-like receptor 4
SN-38, the active metabolite of irinotecan, inhibits the acute inflammatory response by targeting toll-like receptor 4
Material Type:
Artigo 		Adicionar ao Meu Espaço

SN-38, the active metabolite of irinotecan, inhibits the acute inflammatory response by targeting toll-like receptor 4

Deysi Viviana T. Wong Helder Veras Ribeiro Filho; Carlos Wagner Souza Wanderley; Caio Abner Vitorino Gonçalves Leite; Jonilson Berlink Lima; Alexia Nathália Brígido Assef; Aurilene Gomes Cajado; Gabriela Loiola Ponte Batista; Rafael Holanda González; Karla Oliveira Silva; Luis Philipi Carvalho Borges; Nylane Maria Nunes de Alencar; Diego Veras Wilke; Thiago Mattar Cunha; Ana Carolina Migliorini Figueira; Fernando de Queiroz Cunha; Roberto César P Lima Júnior

Cancer Chemotherapy and Pharmacology Heidelberg v. 84, n. 2, p. 287-298, 2019

Heidelberg 2019

Localização: FMRP - Fac. Medicina de Ribeirão Preto    (pcd 3011835 Acervo Digital )(Acessar)

2
Development, Characterization, and Evaluation of SLN-Loaded Thermoresponsive Hydrogel System of Topotecan as Biological Macromolecule for Colorectal Delivery
Development, Characterization, and Evaluation of SLN-Loaded Thermoresponsive Hydrogel System of Topotecan as Biological Macromolecule for Colorectal Delivery
Material Type:
Artigo 		Adicionar ao Meu Espaço

Development, Characterization, and Evaluation of SLN-Loaded Thermoresponsive Hydrogel System of Topotecan as Biological Macromolecule for Colorectal Delivery

Xing, R. ; Mustapha, O. ; Ali, T. ; Rehman, M. ; Zaidi, S. S. ; Baseer, A. ; Batool, S. ; Mukhtiar, M. ; Shafique, S. ; Malik, M. ; Sohail, S. ; Ali, Z. ; Zahid, F. ; Zeb, A. ; Shah, F. ; Yousaf, A. ; Din, F. Di Stefano, Luisa ; Luisa Di Stefano

BioMed research international, 2021, Vol.2021, p.9968602-14 [Periódico revisado por pares]

United States: Hindawi

Texto completo disponível

Citações Citado por
3
Targeting Topoisomerase I in the Era of Precision Medicine
Targeting Topoisomerase I in the Era of Precision Medicine
Material Type:
Artigo 		Adicionar ao Meu Espaço

Targeting Topoisomerase I in the Era of Precision Medicine

Thomas, Anish ; Pommier, Yves

Clinical cancer research, 2019-11, Vol.25 (22), p.6581-6589 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por
4
Bevacizumab Combined With Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer: The AURELIA Open-Label Randomized Phase III Trial
Bevacizumab Combined With Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer: The AURELIA Open-Label Randomized Phase III Trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Bevacizumab Combined With Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer: The AURELIA Open-Label Randomized Phase III Trial

PUJADE-LAURAINE, Eric ; HILPERT, Felix ; PEREIRA, Deolinda ; WIMBERGER, Pauline ; OAKNIN, Ana ; MIRZA, Mansoor Raza ; FOLLANA, Philippe ; BOLLAG, David ; RAY-COQUARD, Isabelle ; WEBER, Béatrice ; REUSS, Alexander ; POVEDA, Andres ; KRISTENSEN, Gunnar ; SORIO, Roberto ; VERGOTE, Ignace ; WITTEVEEN, Petronella ; BAMIAS, Aristotelis

Journal of clinical oncology, 2014-05, Vol.32 (13), p.1302-1308 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
5
Development of topotecan loaded lipid nanoparticles for chemical stabilization and prolonged release
Development of topotecan loaded lipid nanoparticles for chemical stabilization and prolonged release
Material Type:
Artigo 		Adicionar ao Meu Espaço

Development of topotecan loaded lipid nanoparticles for chemical stabilization and prolonged release

Souza, L.G. ; Silva, E.J. ; Martins, A.L.L. ; Mota, M.F. ; Braga, R.C. ; Lima, E.M. ; Valadares, M.C. ; Taveira, S.F. ; Marreto, R.N.

European journal of pharmaceutics and biopharmaceutics, 2011-09, Vol.79 (1), p.189-196 [Periódico revisado por pares]

Netherlands: Elsevier B.V

Texto completo disponível

Citações Citado por
6
Image-guided thermosensitive liposomes for focused ultrasound drug delivery: Using NIRF-labelled lipids and topotecan to visualise the effects of hyperthermia in tumours
Image-guided thermosensitive liposomes for focused ultrasound drug delivery: Using NIRF-labelled lipids and topotecan to visualise the effects of hyperthermia in tumours
Material Type:
Artigo 		Adicionar ao Meu Espaço

Image-guided thermosensitive liposomes for focused ultrasound drug delivery: Using NIRF-labelled lipids and topotecan to visualise the effects of hyperthermia in tumours

Centelles, Miguel N. ; Wright, Michael ; So, Po-Wah ; Amrahli, Maral ; Xu, Xiao Yun ; Stebbing, Justin ; Miller, Andrew D. ; Gedroyc, Wladyslaw ; Thanou, Maya

Journal of controlled release, 2018-06, Vol.280, p.87-98 [Periódico revisado por pares]

Netherlands: Elsevier B.V

Texto completo disponível

Citações Citado por
7
ATM orchestrates the DNA-damage response to counter toxic non-homologous end-joining at broken replication forks
ATM orchestrates the DNA-damage response to counter toxic non-homologous end-joining at broken replication forks
Material Type:
Artigo 		Adicionar ao Meu Espaço

ATM orchestrates the DNA-damage response to counter toxic non-homologous end-joining at broken replication forks

Balmus, Gabriel ; Pilger, Domenic ; Coates, Julia ; Demir, Mukerrem ; Sczaniecka-Clift, Matylda ; Barros, Ana C ; Woods, Michael ; Fu, Beiyuan ; Yang, Fengtang ; Chen, Elisabeth ; Ostermaier, Matthias ; Stankovic, Tatjana ; Ponstingl, Hannes ; Herzog, Mareike ; Yusa, Kosuke ; Martinez, Francisco Munoz ; Durant, Stephen T ; Galanty, Yaron ; Beli, Petra ; Adams, David J ; Bradley, Allan ; Metzakopian, Emmanouil ; Forment, Josep V ; Jackson, Stephen P

Nature communications, 2019-01, Vol.10 (1), p.87-18, Article 87 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
8
Carboplatin plus etoposide versus topotecan as second-line treatment for patients with sensitive relapsed small-cell lung cancer: an open-label, multicentre, randomised, phase 3 trial
Carboplatin plus etoposide versus topotecan as second-line treatment for patients with sensitive relapsed small-cell lung cancer: an open-label, multicentre, randomised, phase 3 trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Carboplatin plus etoposide versus topotecan as second-line treatment for patients with sensitive relapsed small-cell lung cancer: an open-label, multicentre, randomised, phase 3 trial

Baize, Nathalie ; Monnet, Isabelle ; Greillier, Laurent ; Geier, Margaux ; Lena, Hervé ; Janicot, Henri ; Vergnenegre, Alain ; Crequit, Jacky ; Lamy, Regine ; Auliac, Jean-Bernard ; Letreut, Jacques ; Le Caer, Hervé ; Gervais, Radj ; Dansin, Eric ; Madroszyk, Anne ; Renault, Patrick-Aldo ; Le Garff, Gwenaëlle ; Falchero, Lionel ; Berard, Henri ; Schott, Roland ; Saulnier, Patrick ; Chouaid, Christos

The lancet oncology, 2020-09, Vol.21 (9), p.1224-1233 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
9
A Phase I Clinical Trial of the Poly(ADP-ribose) Polymerase Inhibitor Veliparib and Weekly Topotecan in Patients with Solid Tumors
A Phase I Clinical Trial of the Poly(ADP-ribose) Polymerase Inhibitor Veliparib and Weekly Topotecan in Patients with Solid Tumors
Material Type:
Artigo 		Adicionar ao Meu Espaço

A Phase I Clinical Trial of the Poly(ADP-ribose) Polymerase Inhibitor Veliparib and Weekly Topotecan in Patients with Solid Tumors

Wahner Hendrickson, Andrea E ; Menefee, Michael E ; Hartmann, Lynn C ; Long, Harry J ; Northfelt, Donald W ; Reid, Joel M ; Boakye-Agyeman, Felix ; Kayode, Olumide ; Flatten, Karen S ; Harrell, Maria I ; Swisher, Elizabeth M ; Poirier, Guy G ; Satele, Daniel ; Allred, Jake ; Lensing, Janet L ; Chen, Alice ; Ji, Jiuping ; Zang, Yiping ; Erlichman, Charles ; Haluska, Paul ; Kaufmann, Scott H

Clinical cancer research, 2018-02, Vol.24 (4), p.744-752 [Periódico revisado por pares]

United States: American Association for Cancer Research Inc

Texto completo disponível

Citações Citado por
10
Development of a highly stable and targetable nanoliposomal formulation of topotecan
Development of a highly stable and targetable nanoliposomal formulation of topotecan
Material Type:
Artigo 		Adicionar ao Meu Espaço

Development of a highly stable and targetable nanoliposomal formulation of topotecan

Drummond, Daryl C. ; Noble, Charles O. ; Guo, Zexiong ; Hayes, Mark E. ; Connolly-Ingram, Ceirin ; Gabriel, Bianca S. ; Hann, Byron ; Liu, Bin ; Park, John W. ; Hong, Keelung ; Benz, Christopher C. ; Marks, James D. ; Kirpotin, Dmitri B.

Journal of controlled release, 2010-01, Vol.141 (1), p.13-21 [Periódico revisado por pares]

Kidlington: Elsevier B.V

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Data de Publicação 

De até
Refinar
  1. Antes de1995  (69)
  2. 1995Até2001  (606)
  3. 2002Até2008  (841)
  4. 2009Até2016  (747)
  5. Após 2016  (595)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (2.731)
  2. Chinês  (40)
  3. Japonês  (23)
  4. Francês  (21)
  5. Coreano  (17)
  6. Alemão  (12)
  7. Russo  (10)
  8. Italiano  (7)
  9. Polonês  (4)
  10. Húngaro  (4)
  11. Português  (3)
  12. Espanhol  (3)
  13. Persa  (1)
  14. Lituano  (1)
  15. Mais opções open sub menu

Novas Pesquisas Sugeridas

Ignorar minha busca e procurar por tudo

Deste Autor:

  1. Wanderley, C
  2. Alencar, N
  3. Cunha, F
  4. Wilke, D
  5. Wong, D

Neste Assunto:

  1. Science & Technology
  2. Life Sciences & Biomedicine
  3. Humans
  4. Topotecan
  5. Oncology

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.